Pharma Exclusives Pressreleases
BioMed X and Servier Launch First Research Team in France to Pioneer AI-Driven Antibody Engineering
Thursday, April 16, 2026BioMed X a leading innovation hub for pharma has officially launched its first research team at BioMed X France marking the establishment of its presence in one of Europes fastestgrowing life science ecosystems
Novo Nordisk and OpenAI partner to transform how medicines are discovered and delivered
Tuesday, April 14, 2026Novo Nordisk today announced a strategic partnership with OpenAI that will place Novo Nordisk at the forefront of AI transformation in healthcare and help the company bring new and better treatment options to patients faster
Vetter Strengthens its Global Clinical Manufacturing Network with Strategic Site Enhancements
Tuesday, April 14, 2026Vetter a leading global Contract Development and Manufacturing Organization CDMO announced significant progress in the continued expansion of its global clinical manufacturing network With the ongoing scaleup
Touchlight Partners with SVF Vaccines to Advance Innovative Hepatitis B/D Vaccine to Clinic
Thursday, April 09, 2026Touchlight a leading biotechnology company specialising in cellfree DNA manufacturing is proud to announce a strategic partnership with SVF Vaccines to progress SVFs innovative Hepatitis BD vaccine into clinical development
European Commission approves KYGEVVI®▼ (doxecitine and doxribtimine) as first and only treatment for Thymidine Kinase 2 Deficiency (TK2d)
Tuesday, March 31, 2026UCB Euronext Brussels UCB a global biopharmaceutical company today announced that the European Commission EC has granted marketing authorization under exceptional circumstances for KYGEVVI
Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation
Wednesday, March 25, 2026Zealand Pharma AS Nasdaq ZEAL CVRno a biotechnology company transforming the future of metabolic health today announced the establishment of a new research hub in Cambridge Massachusetts in the greater Boston area
Thermo Fisher Scientific Introduces New Laboratory Developed Test to Help Transplant Patients Receive the Right Dose of Critical Anti-Rejection Medication Sooner
Friday, February 27, 2026Thermo Fisher Scientific the world leader in serving science today announced the launch of the TacroType Pharmacogenetic Test a new laboratory developed test designed to help inform clinicians on dosing tacrolimus
Novo Nordisk and Vivtex partner to develop next-generation oral medicines for obesity and diabetes
Thursday, February 26, 2026Novo Nordisk and Vivtex Corporation today announced a partnership to develop nextgeneration oral biologic medicines for obesity diabetes and associated comorbidities
Hansa Biopharma’s Biologics License Application (BLA) for imlifidase accepted by the FDA
Thursday, February 19, 2026Hansa Biopharma AB Hansa or the Company Nasdaq Stockholm HNSA today announced that its Biologics License Application BLA for imlifidase has been accepted by the US Food and Drug Administration FDA
LEON and Harro Höfliger Announce Strategic Collaboration for Global Distribution and After-Sales Service of Nanoencapsulation Equipment
Thursday, February 19, 2026Leonnanodrugs GmbH LEON a leading developer of advanced nanoencapsulation technology and equipment and Harro Hfliger a global expert in pharmaceutical engineering and GMPcompliant production
